Table 1.
The published studies of HPV and breast cancer in case-control setting
| Study | Country | Case (n = 1,833) |
Control (n = 893) |
||
|---|---|---|---|---|---|
| HPV (+) | HPV (–) | HPV (+) | HPV (–) | ||
| Bratthauer et al. [34] (1992) | USA | 0 | 28 | 0 | 15 |
| Yu et al. [5] (1999) | China, Japan | 18 | 34 | 1 | 19 |
| Damin et al. [7] (2004) | Brazil | 25 | 76 | 0 | 41 |
| Tsai et al. [8] (2005) | Taiwan | 8 | 54 | 2 | 42 |
| Choi et al. [9] (2007) | Korea | 8 | 115 | 0 | 31 |
| de Leon et al. [11] (2009) | Mexico | 15 | 36 | 0 | 43 |
| He et al. [12] (2009) | China | 24 | 16 | 1 | 19 |
| Heng et al. [13] (2009) | Australia | 8 | 20 | 3 | 25 |
| Mendizabal-Ruiz et al. [14] (2009) | Mexico | 3 | 64 | 0 | 40 |
| Mou et al. [15] (2011) | China | 4 | 58 | 0 | 46 |
| Chang et al. [35] (2012) | China | 0 | 48 | 0 | 30 |
| Frega et al. [16] (2012) | Italy | 9 | 22 | 0 | 12 |
| Glenn et al. [17] (2012) | Australia | 35 | 42 | 11 | 47 |
| Sigaroodi et al. [18] (2012) | Iran | 15 | 43 | 1 | 40 |
| Liang et al. [19] (2013) | China | 48 | 176 | 6 | 31 |
| Ali et al. [23] (2014) | Iraq | 60 | 69 | 3 | 41 |
| Ahangar-Oskouee et al. [24] (2014) | Iran | 22 | 43 | 0 | 65 |
| Manzouri et al. [25] (2014) | Iran | 10 | 45 | 7 | 44 |
| Peng et al. [26] (2014) | China | 2 | 98 | 0 | 50 |
| Fu et al. [36] (2015) | China | 25 | 144 | 1 | 82 |
| Vernet-Tomas et al. [33] (2015) | Spain | 0 | 76 | 0 | 2 |
| Li et al. [28] (2015) | China | 3 | 184 | 0 | 92 |
| Total | 342 | 1491 | 36 | 857 | |
HPV, human papillomavirus.